Biotechnology Institute Thurgau at the University of Konstanz
Publications Oliver Gerken
- Melgrati S, Gerken OJ, Artinger M, Radice E, Szpakowska M, Chevigné A, D'Uonnolo G, Antonello P, Thelen S, Pelczar P, Legler DF, Thelen M. 2023. GPR182 is a broadly scavenging atypical chemokine receptor influencing T-independent immunity. Front Immunol DOI: 10.3389/fimmu.2023.1242531.
- Artinger M, Gerken OJ, Legler DF. 2023. Heparin Specifically Interacts with Basic BBXB Motifs of the Chemokine CCL21 to Define CCR7 Signaling. Int J Mol Sci Jan 14;24(2):1670. doi: 10.3390/ijms24021670.
- Artinger M, Gerken OJ, Purvanov V, Legler DF. 2022. Distinct Fates of Chemokine and Surrogate Molecule Gradients: Consequences for CCR7-Guided Dendritic Cell Migration. Front Immunol 13:913366. doi: 10.3389/fimmu.2022.913366.
- Gerken OJ, Artinger M, Legler DF. 2022. Shifting CCR7 towards Its Monomeric Form Augments CCL19 Binding and Uptake. Cells Apr 25;11(9):1444. doi: 10.3390/cells11091444.
- Artinger M, Matti C, Gerken OJ, Veldkamp CT, Legler DF. 2021. A Versatile Toolkit for Semi-Automated Production of Fluorescent Chemokines to Study CCR7 Expression and Functions. Int J Mol Sci Apr 16;22(8):4158. doi: 10.3390/ijms22084158.
